New data show that wearable neuromodulation can be used with CGMs without disrupting glucose accuracy or connectivity.
Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — Cardiac neuromodulation therapy resulted in significant reductions in systolic BP at 6 months in ...
Surf Therapeutics, a clinical-stage company developing non-invasive ultrasound neuromodulation therapies to treat ...
CORAL SPRINGS, Fla., Jan. 12, 2026 /PRNewswire/ -- Neurolief Inc., a medical device company focused on neuromodulation therapies for neuropsychiatric conditions, today announced that the U.S. Food and ...
Noninvasive peripheral nerve stimulation applied repeatedly at home over a 3-month period reduced hand tremors in patients with essential tremor (ET), new research shows. In a large prospective study, ...
The Louisiana-based company offers its Ellipse Spinal Cord Stimulator Platform for treating chronic pain. The platform includes the company's patented and FDA-cleared StimuLux technology, which uses ...
Epilepsy is one of the most common neurological diseases, affecting around 50 million people worldwide, and carries a debilitating burden for the patient. It is characterized by recurrent seizures ...
Abbott announced today that it has updated NeuroSphere, its app-driven neuromodulation therapy platform, with remote programming capabilities that will allow patients to speak with and receive ...
New data confirm Revi’s unmatched durability, 95% patient satisfaction, and excellent safety over three years, setting a new standard in Implantable Tibial Neuromodulation SALT LAKE CITY--(BUSINESS ...
First customer sites include the University of Arkansas for Medical Sciences, MUSC Health, and Calif.-based Acacia Clinics and Kaizen Brain Center BURLINGAME, Calif.--(BUSINESS WIRE)--Magnus Medical, ...
This post was co-authored by Abigail Ramos and Robert T. Muller, Ph.D. With the development of new neuro-technology and emerging research on the function of the brain, the treatment of mental illness ...
New Investigational Device Aims to Expand Access to Therapy for Patients with Incontinence; Underscores Medtronic's Leadership as Only Company to Offer Neuromodulation Options for Incontinence DUBLIN, ...